Have Patent, Will Travel: Brand Firms Can File Infringement Suits Anywhere
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Circuit denies Mylan's bid to dismiss litigation in Delaware; PhRMA, BIO and Teva argued that brand manufacturers should be allowed to sue multiple generic manufacturers in a single forum.